Phaseline

Companies › TBF Genie Tissulaire

TBF Genie Tissulaire: clinical trials, targets and expected readouts

5 active drug programs in 6 registered trials: 4 Phase 2, 2 Phase 3; Immunology, Ophthalmology, Genitourinary, Other; next expected readout Nov 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
treated umbilical vein allograft (UVT)
surgical sling made from treated allogeneic umbilical vein
–Phase 3Stress Urinary Incontinence in WomenMay 2028
Therapeutic lens + amniotic membrane–Phase 3Progressive Keratoconus–
SclerFIX-IP
Decellularized, viro-inactivated, freeze-dried allogeneic amniotic membrane graft for join
–Phase 2Osteoarthritis HandNov 2026
SclerFIX
Treated, devitalized and sterile umbilical cord amniotic membrane allograft for interposit
–Phase 2Trapeziometacarpal OsteoarthritisMar 2028
AMTRIX-D
Decellularized, viro-inactivated amniotic membrane graft functioning as anti-adhesive barr
–Phase 2Tendon Adhesion–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT06034262SclerFIX-IPPhase 2Osteoarthritis HandImmunologyOct 2025
NCT06450470Therapeutic lens + amniotic membranePhase 3Progressive KeratoconusOphthalmologyNov 2025
NCT06723782AMTRIX-DPhase 2Tendon AdhesionOtherSep 2026
NCT06038331SclerFIX-IPPhase 2Osteoarthritis HandImmunologyNov 2026
NCT07435571SclerFIXPhase 2Trapeziometacarpal OsteoarthritisImmunologyMar 2028
NCT06678984treated umbilical vein allograft (UVT)Phase 3Stress Urinary Incontinence in WomenGenitourinaryMay 2028

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Medipost Nature Cell Throne Biotechnologies Cellcolabs Clinical SPV EHL Bio

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.